Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Venture Capital Survey Paints Bleak Portrait

Oct 01 2012

• By Alex Lash and Tom Salemi

Related Content

“Breakthrough Therapy”: New Pathway in FDASIA May Point The Way To Future Reforms

Aug 16 2012

FDA Approves Vivus’ Obesity Drug, Recommends Against Use In High-Risk Heart Patients

Jul 18 2012

START-UP's 2011 Life Science Venture Capital Survey: Biopharmaceutical Investors Let Some Sunshine In

Sep 01 2011

BMS' Purchase Of Amira: When An Acquisition Is Really An Asset Sale

Sep 01 2011

Corporate Venture Eyes The Early Stage

Sep 13 2012

No Obvious Prescription For Biopharma Investors

Sep 13 2012

Related Companies

Astria Therapeutics, Inc.

Rhythm Pharmaceuticals, Inc.

Ember Therapeutics, Inc.

Arena Pharmaceuticals, Inc.

Vivus, Inc.

Johnson & Johnson

GSK plc

Additional Topics

United States Europe Deals Business Strategies Regulation BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window